Your session is about to expire
← Back to Search
Corticosteroid
Mometasone 1mg for Chronic Sinusitis
Phase 1
Waitlist Available
Led By Bobby Tajudeen, MD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up morning (am) at week 12,
Awards & highlights
No Placebo-Only Group
Summary
This trial tests different doses of mometasone in nasal irrigation for patients with chronic sinusitis. The goal is to see if it affects cortisol levels in the body. Mometasone helps reduce nasal inflammation and is less likely to enter the bloodstream, making it safer for long-term use. Mometasone furoate has been used in various forms, such as nasal sprays and gels, to treat sinusitis and reduce nasal inflammation.
Eligible Conditions
- Chronic Sinusitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ morning (am) at week 12,
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~morning (am) at week 12,
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Morning "AM" Serum Cortisol Level
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Mometasone 4mgExperimental Treatment1 Intervention
4mg capsule dissolved in 240mg saline solution nasal irrigation
Group II: Mometasone 2mgExperimental Treatment1 Intervention
2mg capsule dissolved in 240mg saline solution nasal irrigation
Group III: Mometasone 1mgExperimental Treatment1 Intervention
1mg capsule dissolved in 240mg saline solution nasal irrigation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mometasone
Not yet FDA approved
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
435 Previous Clinical Trials
249,278 Total Patients Enrolled
Advanced RxIndustry Sponsor
Bobby Tajudeen, MDPrincipal InvestigatorRush University Medical Center
Share this study with friends
Copy Link
Messenger